[89Zr]Zr-DFO-Lys-Trop-2.2

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug Name[89Zr]Zr-DFO-Lys-Trop-2.2
Drug Alias Name[89Zr]Zr-DFO-Lys-Trop-2.2[89Zr]Zr-DFO-Trop2[89Zr]Zr-DFO-Trop-2.2
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radionuclide Drug Conjugates +[5] 
Mechanisms of ActionAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And CompanyWeill Cornell Medical College
China Registration ClassN/A

Develop Information

Active CompaniesWeill Cornell Medical College
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A